Market Cap 241.21M
Revenue (ttm) 0.00
Net Income (ttm) -74.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,525,900
Avg Vol 2,864,120
Day's Range N/A - N/A
Shares Out 66.63M
Stochastic %K 72%
Beta 3.01
Analysts Hold
Price Target $5.43

Company Profile

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers programs for the treatment of diamond-blackfan anemia, Bone Marrow Fa...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 651 8851
Address:
26 Landsdowne Street, Cambridge, United States
FilingTracker
FilingTracker Jul. 21 at 1:11 AM
$FULC More insider purchasing: https://filingtracker.ai/filing/1680581/0001178579-26-000016
0 · Reply
G101SPM
G101SPM Jul. 16 at 5:15 PM
#INSIDERS $FULC 10% owner Keven Tang (Tang Capital) bought another 249,946 shares at $3.54 - $3.55 worth approximately $891K (transaction dates 7/13-7/15). $HNRG Director bought 5,000 shares at $17.12 - $17.13 worth approximately $86K (transaction date 7/14). $SLGL 10% owner Opaleye Management bought 1,695 shares at $73.34 - $73.95 worth approximately $125K (transaction dates 7/13-7/14). $PB Director sold 1,100 shares worth approximately $80K (transaction date 7/15).
0 · Reply
GeneralGainz
GeneralGainz Jul. 16 at 3:25 PM
$SPRO CEO of Spero was CFO at $FULC this was the time frame she was there. Looking at their chart to see performance during her time there.
0 · Reply
FilingTracker
FilingTracker Jul. 15 at 11:54 PM
$FULC Insider purchase: https://filingtracker.ai/filing/1178579/0001178579-26-000014?doc=form4-07152026_110717.xml
0 · Reply
Zackpedia
Zackpedia Jul. 10 at 3:26 PM
$FULC You could’ve sold when I alerted and bought back at 3.4 now if you wanted.
0 · Reply
Zackpedia
Zackpedia Jul. 9 at 5:49 PM
$FULC Down to 3.56, you could’ve sold when I alerted and bought back today if you wanted!
0 · Reply
jazzv
jazzv Jul. 9 at 5:37 PM
$FULC what is co's exit plan? reverse merger?
0 · Reply
Zackpedia
Zackpedia Jun. 24 at 7:28 PM
$FULC Went down to 3.66, you could’ve sold when I alerted…
0 · Reply
MikeyMcDermott
MikeyMcDermott Jun. 24 at 4:44 PM
Let's hope $SPRO & $GSK lose out on there "next phase of growth" for not acting swiftly and boldly. There is already a clean, willing and able cash shell $FULC in Cambridge with $300 million + cash. FULC was a sickle cell disease failure (unfortunately) but at least the Board MOVES quickly. -- cut 85% of staff; put in retention bonuses for remaining management/employees, cut burn rate drastically, all to drive a reverse merger. Shit is happening in Cambridge, MA.
1 · Reply
Zackpedia
Zackpedia Jun. 24 at 2:28 PM
$FULC Selling time at 4!
0 · Reply
Latest News on FULC
Goldman suspends rating on Fulcrum Therapeutics

2026-06-02T20:18:59.000Z - 7 weeks ago

Goldman suspends rating on Fulcrum Therapeutics


Fulcrum Therapeutics downgraded to Hold from Buy at Truist

2026-06-02T09:15:40.000Z - 7 weeks ago

Fulcrum Therapeutics downgraded to Hold from Buy at Truist


Fulcrum Therapeutics downgraded to Hold from Buy at Stifel

2026-06-02T00:30:10.000Z - 7 weeks ago

Fulcrum Therapeutics downgraded to Hold from Buy at Stifel


Fulcrum Therapeutics price target raised to $8 from $7 at BofA

2026-05-10T14:35:48.000Z - 2 months ago

Fulcrum Therapeutics price target raised to $8 from $7 at BofA


Fulcrum Therapeutics Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

Fulcrum Therapeutics Proxy statement: Proxy filing


Fulcrum Therapeutics Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

Fulcrum Therapeutics Proxy statement: Proxy filing


Fulcrum Therapeutics Earnings Call Transcript: Q1 2026

Apr 27, 2026, 8:00 AM EDT - 3 months ago

Fulcrum Therapeutics Earnings Call Transcript: Q1 2026


Fulcrum Therapeutics Earnings release: Q1 2026

Apr 27, 2026, 8:00 AM EDT - 3 months ago

Fulcrum Therapeutics Earnings release: Q1 2026


Fulcrum Therapeutics Quarterly report: Q1 2026

Apr 27, 2026, 8:00 AM EDT - 3 months ago

Fulcrum Therapeutics Quarterly report: Q1 2026


Fulcrum Therapeutics reports Q1 EPS (25c), consensus (30c)

2026-04-27T11:56:41.000Z - 3 months ago

Fulcrum Therapeutics reports Q1 EPS (25c), consensus (30c)


Fulcrum Therapeutics CFO Alan Musso to retire

2026-04-27T11:56:23.000Z - 3 months ago

Fulcrum Therapeutics CFO Alan Musso to retire


Fulcrum Therapeutics Slides: Corporate presentation

Apr 22, 2026, 7:00 AM EDT - 3 months ago

Fulcrum Therapeutics Slides: Corporate presentation


Fulcrum Therapeutics Slides: Corporate presentation

Mar 6, 2026, 6:00 AM EST - 4 months ago

Fulcrum Therapeutics Slides: Corporate presentation


Fulcrum Therapeutics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 8:00 AM EST - 5 months ago

Fulcrum Therapeutics Earnings Call Transcript: Q4 2025


Fulcrum Therapeutics Annual report: Q4 2025

Feb 24, 2026, 8:00 AM EST - 5 months ago

Fulcrum Therapeutics Annual report: Q4 2025


Fulcrum Therapeutics Earnings release: Q4 2025

Feb 24, 2026, 8:00 AM EST - 5 months ago

Fulcrum Therapeutics Earnings release: Q4 2025


Fulcrum Therapeutics Slides: Corporate presentation

Jan 10, 2026, 7:00 AM EST - 6 months ago

Fulcrum Therapeutics Slides: Corporate presentation


Fulcrum Therapeutics Transcript: Status Update

Dec 7, 2025, 7:00 AM EST - 8 months ago

Fulcrum Therapeutics Transcript: Status Update


Fulcrum Therapeutics Press release: Status Update

Dec 7, 2025, 7:00 AM EST - 8 months ago

Fulcrum Therapeutics Press release: Status Update


Fulcrum Therapeutics Slides: Status Update

Dec 7, 2025, 7:00 AM EST - 8 months ago

Fulcrum Therapeutics Slides: Status Update


Fulcrum Therapeutics Earnings Call Transcript: Q3 2025

Oct 29, 2025, 8:00 AM EDT - 9 months ago

Fulcrum Therapeutics Earnings Call Transcript: Q3 2025


Fulcrum Therapeutics Quarterly report: Q3 2025

Oct 29, 2025, 8:00 AM EDT - 9 months ago

Fulcrum Therapeutics Quarterly report: Q3 2025


Fulcrum Therapeutics Earnings release: Q3 2025

Oct 29, 2025, 8:00 AM EDT - 9 months ago

Fulcrum Therapeutics Earnings release: Q3 2025


Fulcrum Therapeutics to Present at Upcoming Investor Meetings

Aug 26, 2025, 8:00 AM EDT - 11 months ago

Fulcrum Therapeutics to Present at Upcoming Investor Meetings


Fulcrum Therapeutics Earnings release: Q2 2025

Jul 29, 2025, 4:00 PM EDT - 1 year ago

Fulcrum Therapeutics Earnings release: Q2 2025


Fulcrum Therapeutics Quarterly report: Q2 2025

Jul 29, 2025, 4:00 PM EDT - 1 year ago

Fulcrum Therapeutics Quarterly report: Q2 2025


Fulcrum Therapeutics to Present at Upcoming Medical Meetings

May 29, 2025, 4:10 PM EDT - 1 year ago

Fulcrum Therapeutics to Present at Upcoming Medical Meetings


Fulcrum Therapeutics Proxy statement: Proxy Filing

May 7, 2025, 8:00 AM EDT - 1 year ago

Fulcrum Therapeutics Proxy statement: Proxy Filing


Fulcrum Therapeutics Earnings Call Transcript: Q1 2025

May 1, 2025, 8:00 AM EDT - 1 year ago

Fulcrum Therapeutics Earnings Call Transcript: Q1 2025


Fulcrum Therapeutics Quarterly report: Q1 2025

May 1, 2025, 8:00 AM EDT - 1 year ago

Fulcrum Therapeutics Quarterly report: Q1 2025


Fulcrum Therapeutics Earnings release: Q1 2025

May 1, 2025, 8:00 AM EDT - 1 year ago

Fulcrum Therapeutics Earnings release: Q1 2025


Fulcrum Therapeutics Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Fulcrum Therapeutics Proxy statement: Proxy Filing


Fulcrum Therapeutics Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Fulcrum Therapeutics Proxy statement: Proxy Filing


Fulcrum Therapeutics Earnings Call Transcript: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

Fulcrum Therapeutics Earnings Call Transcript: Q4 2024


Fulcrum Therapeutics Annual report: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

Fulcrum Therapeutics Annual report: Q4 2024


Fulcrum Therapeutics Earnings release: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

Fulcrum Therapeutics Earnings release: Q4 2024


Fulcrum Therapeutics Earnings Call Transcript: Q3 2024

Nov 13, 2024, 8:00 AM EST - 1 year ago

Fulcrum Therapeutics Earnings Call Transcript: Q3 2024


Fulcrum Therapeutics Quarterly report: Q3 2024

Nov 13, 2024, 8:00 AM EST - 1 year ago

Fulcrum Therapeutics Quarterly report: Q3 2024


Fulcrum Therapeutics Earnings release: Q3 2024

Nov 13, 2024, 8:00 AM EST - 1 year ago

Fulcrum Therapeutics Earnings release: Q3 2024


FilingTracker
FilingTracker Jul. 21 at 1:11 AM
$FULC More insider purchasing: https://filingtracker.ai/filing/1680581/0001178579-26-000016
0 · Reply
G101SPM
G101SPM Jul. 16 at 5:15 PM
#INSIDERS $FULC 10% owner Keven Tang (Tang Capital) bought another 249,946 shares at $3.54 - $3.55 worth approximately $891K (transaction dates 7/13-7/15). $HNRG Director bought 5,000 shares at $17.12 - $17.13 worth approximately $86K (transaction date 7/14). $SLGL 10% owner Opaleye Management bought 1,695 shares at $73.34 - $73.95 worth approximately $125K (transaction dates 7/13-7/14). $PB Director sold 1,100 shares worth approximately $80K (transaction date 7/15).
0 · Reply
GeneralGainz
GeneralGainz Jul. 16 at 3:25 PM
$SPRO CEO of Spero was CFO at $FULC this was the time frame she was there. Looking at their chart to see performance during her time there.
0 · Reply
FilingTracker
FilingTracker Jul. 15 at 11:54 PM
$FULC Insider purchase: https://filingtracker.ai/filing/1178579/0001178579-26-000014?doc=form4-07152026_110717.xml
0 · Reply
Zackpedia
Zackpedia Jul. 10 at 3:26 PM
$FULC You could’ve sold when I alerted and bought back at 3.4 now if you wanted.
0 · Reply
Zackpedia
Zackpedia Jul. 9 at 5:49 PM
$FULC Down to 3.56, you could’ve sold when I alerted and bought back today if you wanted!
0 · Reply
jazzv
jazzv Jul. 9 at 5:37 PM
$FULC what is co's exit plan? reverse merger?
0 · Reply
Zackpedia
Zackpedia Jun. 24 at 7:28 PM
$FULC Went down to 3.66, you could’ve sold when I alerted…
0 · Reply
MikeyMcDermott
MikeyMcDermott Jun. 24 at 4:44 PM
Let's hope $SPRO & $GSK lose out on there "next phase of growth" for not acting swiftly and boldly. There is already a clean, willing and able cash shell $FULC in Cambridge with $300 million + cash. FULC was a sickle cell disease failure (unfortunately) but at least the Board MOVES quickly. -- cut 85% of staff; put in retention bonuses for remaining management/employees, cut burn rate drastically, all to drive a reverse merger. Shit is happening in Cambridge, MA.
1 · Reply
Zackpedia
Zackpedia Jun. 24 at 2:28 PM
$FULC Selling time at 4!
0 · Reply
MikeyMcDermott
MikeyMcDermott Jun. 22 at 6:45 PM
$SPRO if Spero and GSK lost its reverse merger partner to say $FULC -- why not just take that Cambridge MA Nasdaq shell that has 300 million plus and a WILLING management and Board? If SPERO / $GSK TOOK TOO LONG AND LOST OUT TO FULCRUM THERAPEUTICS -- WHERE IS THE NEXT GROWTH OPPORTUNITY? IF THERE IS NONE ----- PERHAPS WE DO SEE A TENDER OFFER FROM GSK TONIGHT BEFORE THE AGM IF NO REVERSE MERGER PARTNER, THEN NO NEED FOR 120 MILLION NEW SHARES
3 · Reply
MikeyMcDermott
MikeyMcDermott Jun. 22 at 6:19 PM
$SPRO might have lost reverse merger partner to $FULC ? FULC already clean shell with 300 million in the bank. And they already let go 85% of staff. Only 9 employees vs Spero fat pig at 20+!!! These are all Cambridge Massachusetts outfits. Big competition to land their deals? Esther actually came to Spero from Fulcrum! Lots of people in the know I would guess. These are just wild ass guesses but something don't seem right
1 · Reply
SuperGreenToday
SuperGreenToday Jun. 17 at 4:30 AM
$FULC Share Price: $3.44 Contract Selected: Dec 18, 2026 $5 Calls Buy Zone: $0.23 – $0.28 Target Zone: $0.39 – $0.47 Potential Upside: 59% ROI Time to Expiration: 184 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
nightstocker15
nightstocker15 Jun. 12 at 6:17 PM
$FULC looks interesting, see Tang loaded up here 👀
1 · Reply
Zackpedia
Zackpedia Jun. 10 at 3:55 PM
$FULC Down to 3.36 now, you could’ve sold when I alerted and bought back now if you wanted.
0 · Reply
Zackpedia
Zackpedia Jun. 10 at 2:29 PM
$FULC 3.56 again!
0 · Reply
MikeyMcDermott
MikeyMcDermott Jun. 10 at 2:05 PM
$FULC someone taking small shot on July 4c? What if they already identified a reverse merge partner?
1 · Reply
Zackpedia
Zackpedia Jun. 10 at 9:20 AM
$FULC Down to 3.38 now, you could’ve sold when I alerted and bought back now if you wanted.
1 · Reply
Zackpedia
Zackpedia Jun. 9 at 7:39 PM
$FULC And we’re up it’s 3.58 now!
0 · Reply
Zackpedia
Zackpedia Jun. 9 at 2:16 PM
$FULC You could’ve sold at 3.6 today!
0 · Reply
Zackpedia
Zackpedia Jun. 8 at 7:32 PM
$FULC Down to 3.36 now where you can buy back if you want, you could’ve sold when I alerted
0 · Reply
AXLFI_HQ
AXLFI_HQ Jun. 7 at 4:05 PM
$FULC Biotechnology companies face clinical development setbacks and regulatory pathway challenges, forcing workforce reductions and strategic alternatives reviews. Learn more: https://axlfi.com/themes/341
0 · Reply